SCOPE 2023: Uniting Stakeholders With Patient Centricity

This year’s submissions highlight initiatives around accelerating enrollment, personalizing recruitment, increasing diversity, and more.

Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.

The three areas poised for a transformation in the advent of electronic clinical outcome assessment technologies.

Collective investment into leveraging popular culture and mass media as an educational medium is urgently needed.

To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.

Multilayered strategies such as working with patient advocacy organizations and leveraging technology can help industry better partner with patients.